Research ArticleBRAIN
Correlation of Cerebral Metabolites with Functional Outcome in Experimental Primate Stroke Using in Vivo 1H-Magnetic Resonance Spectroscopy
A.L. Coon, F. Arias-Mendoza, G.P. Colby, J. Cruz-Lobo, J. Mocco, W.J. Mack, R.J. Komotar, T.R. Brown and E.S. Connolly
American Journal of Neuroradiology May 2006, 27 (5) 1053-1058;
A.L. Coon
F. Arias-Mendoza
G.P. Colby
J. Cruz-Lobo
J. Mocco
W.J. Mack
R.J. Komotar
T.R. Brown
References
- ↵del Zoppo GJ. Clinical trials in acute stroke: why have they not been successful? Neurology 1998;51(suppl 3):S59–61
- Hoyte L, Kaur J, Buchan AM. Lost in translation: taking neuroprotection from animal models to clinical trials. Exp Neurol 2004;188:200–04
- ↵Wahlgren NG, Ahmed N. Neuroprotection in cerebral ischaemia: facts and fancies–the need for new approaches. Cerebrovasc Dis 2004;17(suppl 1):153–66
- ↵Del Zoppo GJ, Copeland BR, Harker LA, et al. Experimental acute thrombotic stroke in baboons. Stroke 1986;17:1254–65
- Liu XG, Branston NM, Kawauchi M, et al. A model of acute focal ischemia in the territory of the anterior cerebral artery in baboons. Stroke 1992;23:40–44
- ↵Huang J, Mocco J, Choudhri TF, et al. A modified transorbital baboon model of reperfused stroke. Stroke 2000;31:3054–63
- ↵Fukuda S, del Zoppo GJ. Models of focal cerebral ischemia in the nonhuman primate. ILAR J 2003;44:96–104
- ↵
- ↵
- ↵Mack WJ, King RG, Hoh DJ, et al. An improved functional neurological examination for use in nonhuman primate studies of focal reperfused cerebral ischemia. Neurol Res 2003;25:280–84
- ↵Plautz EJ, Barbay S, Frost SB, et al. Post-infarct cortical plasticity and behavioral recovery using concurrent cortical stimulation and rehabilitative training: a feasibility study in primates. Neurol Res 2003;25:801–10
- ↵Kertesz A, Black SE, Nicholson L, et al. The sensitivity and specificity of MRI in stroke. Neurology 1987;37:1580–85
- Bryan RN, Levy LM, Whitlow WD, et al. Diagnosis of acute cerebral infarction: comparison of CT and MR imaging. AJNR Am J Neuroradiol 1991;12:611–20
- Lovblad KO, Baird AE, Schlaug G, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997;42:164–70
- Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418–26
- ↵
- ↵
- ↵Giroud M, Walker P, Guy F, et al. Cerebral metabolism after transient ischemic attack: A 1H MR spectroscopy study. Neurol Res 1999;21:563–65
- ↵Parsons MW, Li T, Barber PA, et al. Combined (1)H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology 2000;55:498–505
- ↵Saunders DE. MR spectroscopy in stroke. Br Med Bull 2000;56:334–45
- ↵Walker PM, Ben Salem D, Lalande A, et al. Time course of NAA T2 and ADC(w) in ischaemic stroke patients: 1H MRS imaging and diffusion-weighted MRI. J Neurol Sci 2004;220:23–28
- ↵Monsein LH, Mathews VP, Barker PB, et al. Irreversible regional cerebral ischemia: serial MR imaging and proton MR spectroscopy in a nonhuman primate model. AJNR Am J Neuroradiol 1993;14:963–70
- ↵Roitberg B, Khan N, Tuccar E, et al. Chronic ischemic stroke model in cynomolgus monkeys: behavioral, neuroimaging and anatomical study. Neurol Res 2003;25:68–78
- ↵Arias-Mendoza F, Brown TR. In vivo measurement of phosphorous markers of disease. Dis Markers 2003;19:49–68
- ↵Graham GD, Blamire AM, Howseman AM, et al. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 1992;23:333–40
- ↵Gideon P, Henriksen O, Sperling B, et al. Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke: a proton magnetic resonance spectroscopy study. Stroke 1992;23:1566–72
- ↵Graham GD, Blamire AM, Rothman DL, et al. Early temporal variation of cerebral metabolites after human stroke: a proton magnetic resonance spectroscopy study. Stroke 1993;24:1891–96
- ↵Demougeot C, Marie C, Giroud M, et al. N-acetylaspartate: a literature review of animal research on brain ischaemia. J Neurochem 2004;90:776–83
- ↵Pereira AC, Saunders DE, Doyle VL, et al. Measurement of initial N-acetyl aspartate concentration by magnetic resonance spectroscopy and initial infarct volume by MRI predicts outcome in patients with middle cerebral artery territory infarction. Stroke 1999;30:1577–82
- ↵Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002;52:20–28
- ↵Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1–15
- ↵Spetzler RF, Selman WR, Weinstein P, et al. Chronic reversible cerebral ischemia: evaluation of a new baboon model. Neurosurgery 1980;7:257–61
- ↵Barber PA, Demchuk AM, Hirt L, et al. Biochemistry of ischemic stroke. Adv Neurol 2003;92:151–64
- ↵Castillo J, Rodriguez I. Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis 2004;17(suppl 1):7–18
- ↵Berkelbach van der Sprenkel JW, Luyten PR, van Rijen PC, et al. Cerebral lactate detected by regional proton magnetic resonance spectroscopy in a patient with cerebral infarction. Stroke 1988;19:1556–60
- ↵Barker PB, Gillard JH, van Zijl PC, et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 1994;192:723–32
- ↵Stengel A, Neumann-Haefelin T, Singer OC, et al. Multiple spin-echo spectroscopic imaging for rapid quantitative assessment of N-acetylaspartate and lactate in acute stroke. Magn Reson Med 2004;52:228–38
- Mathews VP, Barker PB, Blackband SJ, et al. Cerebral metabolites in patients with acute and subacute strokes: concentrations determined by quantitative proton MR spectroscopy. AJR Am J Roentgenol 1995;165:633–38
- ↵Graham GD, Hwang JH, Rothman DL, et al. Spectroscopic assessment of alterations in macromolecule and small-molecule metabolites in human brain after stroke. Stroke 2001;32:2797–802
- ↵Federico F, Simone IL, Lucivero V, et al. Prognostic value of proton magnetic resonance spectroscopy in ischemic stroke. Arch Neurol 1998;55:48–94
- Graham GD, Kalvach P, Blamire AM, et al. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke 1995;26:225–29
- ↵
In this issue
Advertisement
Correlation of Cerebral Metabolites with Functional Outcome in Experimental Primate Stroke Using in Vivo 1H-Magnetic Resonance Spectroscopy
A.L. Coon, F. Arias-Mendoza, G.P. Colby, J. Cruz-Lobo, J. Mocco, W.J. Mack, R.J. Komotar, T.R. Brown, E.S. Connolly
American Journal of Neuroradiology May 2006, 27 (5) 1053-1058;
Correlation of Cerebral Metabolites with Functional Outcome in Experimental Primate Stroke Using in Vivo 1H-Magnetic Resonance Spectroscopy
A.L. Coon, F. Arias-Mendoza, G.P. Colby, J. Cruz-Lobo, J. Mocco, W.J. Mack, R.J. Komotar, T.R. Brown, E.S. Connolly
American Journal of Neuroradiology May 2006, 27 (5) 1053-1058;
Jump to section
Related Articles
- No related articles found.
Cited By...
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement